Physicians' Academy for Cardiovascular Education
Slides: SGLT2 inhibition in cardiology: What is the profile of benefit?

Slides: SGLT2 inhibition in cardiology: What is the profile of benefit?

Presentation Prof. Nikolaus Marx

Slides (presentation) - Aug. 27, 2018 - ESC Congress 2018, Munich - Nikolaus Marx, MD - University Hospital Aachen, Germany

This lecture by prof. Nikolaus Marx was part of a CME accredited symposium Targeting SGLT2 in clinical cardiology: Exploring the benefits in CV risk, diabetes & heart failure held during ESC Congress 2018 in Munich

Download presentation as pdf

View presentation slides

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: